CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.

Ma, Kaiming; Chen, Xin; Liu, Weihai; Chen, Suhua; Yang, Chenlong; Yang, Jun

Ma, Kaiming; Chen, Xin; Liu, Weihai; Chen, Suhua; Yang, Chenlong; Yang, Jun.

Afiliação

Ma K; Department of Neurosurgery, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, China.
Chen X; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Beijing, China.
Liu W; Department of Neurosurgery, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, China.
Chen S; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Beijing, China.
Yang C; Department of Neurosurgery, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, China.
Yang J; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Beijing, China.

Sci Rep ; 12(1): 4295, 2022 03 11.

Article em En | MEDLINE | ID: mdl-35277559

Assuntos

Neoplasias Encefálicas; Glioma; Síndromes de Imunodeficiência; Neoplasias Encefálicas/patologia; Catepsina B/metabolismo; Glioma/patologia; Humanos; Terapia de Imunossupressão; Prognóstico; Regiões Promotoras Genéticas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google